Cargando…
Dedicated Axillary MRI-Based Radiomics Analysis for the Prediction of Axillary Lymph Node Metastasis in Breast Cancer
SIMPLE SUMMARY: The presence of axillary lymph node metastases in breast cancer patients is an essential factor in axillary surgery and possible additional treatment. This study aimed to investigate the potential of dedicated axillary MRI-based radiomics analysis for the prediction of axillary lymph...
Autores principales: | Samiei, Sanaz, Granzier, Renée W. Y., Ibrahim, Abdalla, Primakov, Sergey, Lobbes, Marc B. I., Beets-Tan, Regina G. H., van Nijnatten, Thiemo J. A., Engelen, Sanne M. E., Woodruff, Henry C., Smidt, Marjolein L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917661/ https://www.ncbi.nlm.nih.gov/pubmed/33673071 http://dx.doi.org/10.3390/cancers13040757 |
Ejemplares similares
-
Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer
por: Samiei, Sanaz, et al.
Publicado: (2020) -
MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
por: Granzier, Renée W. Y., et al.
Publicado: (2021) -
Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study
por: van Nijnatten, Thiemo J. A., et al.
Publicado: (2017) -
Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer
por: de Mooij, Cornelis M., et al.
Publicado: (2023) -
Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients
por: Samiei, S., et al.
Publicado: (2019)